PMID: 22216524Dec 1, 1976Paper

Acetylator phenotype and the clinical pharmacology of slow-release procainamide

British Journal of Clinical Pharmacology
W CampbellT D Lawrie

Abstract

Slow-release procainamide given 8-hourly is shown to produce plasma levels generally accepted as giving effective prophylaxis against ventricular dysrhythmias occurring after recent myocardial infarction. Patients can be classified into 'slow' and 'fast' acetylators of procainamide. Knowledge of acetylator status is helpful in determining the dose of procainamide necessary to attain effective steady-state plasma levels while avoiding toxic ones. Acetylator status cannot be assessed accurately using sulphadimidine when the patients are also taking procainamide.

References

Jun 1, 1975·Clinical Pharmacology and Therapeutics·M ReidenbergH Warner
Apr 1, 1975·Clinical Pharmacology and Therapeutics·T P GibsonW A Briggs
Apr 1, 1975·Clinical Pharmacology and Therapeutics·C GraffnerJ Sjögren
Jan 1, 1975·European Journal of Clinical Pharmacology·E KarlssonF Sjöqvist
Mar 17, 1973·Lancet·E C Johnstone, W Marsh
Mar 1, 1974·British Heart Journal·T R ShawJ Hamer
Aug 26, 1972·British Medical Journal·H Schröder
Dec 1, 1973·European Journal of Clinical Pharmacology·E Karlsson
Dec 4, 1969·The New England Journal of Medicine·J Koch-WeserR W DeSanctis
Sep 1, 1972·Archives of Internal Medicine·H S Weily, E Genton
Mar 1, 1971·JAMA : the Journal of the American Medical Association·J Koch-Weser, S W Klein
Jul 6, 1971·Annals of the New York Academy of Sciences·J Koch-Weser
Dec 1, 1969·Journal of Medical Genetics·D A Evans
Jul 1, 1961·British Heart Journal·P C REYNELL
Dec 1, 1974·British Journal of Clinical Pharmacology·E KarlssonF Sjöqvist

Citations

Jan 1, 1983·European Journal of Clinical Pharmacology·P YlitaloT Metsä-Ketelä
Dec 1, 1978·European Journal of Clinical Pharmacology·W J TilstoneT D Lawrie
Jun 19, 1978·European Journal of Clinical Pharmacology·J J LimaW J Jusko
Jan 1, 1980·Pharmacology & Therapeutics·L S Dreifus, J Morganroth
Jan 1, 1989·Pharmacology & Therapeutics·D A Evans
Oct 1, 1977·British Journal of Clinical Pharmacology·D H Lawson, H Jick
Jan 1, 1979·The American Journal of Cardiology·J J LimaW J Jusko
Aug 1, 1984·Journal of Medical Genetics·D A Evans
Oct 24, 2020·Expert Opinion on Drug Metabolism & Toxicology·David W Hein, Lori M Millner

Related Concepts

Acetylation
Cardiac Depressants
Cardiac Arrhythmia
Rhythmin
Myocardial Infarction
Clinical Pharmacology Discipline
Plasma
Sulfamethazine
Ventricular Arrhythmia
Prophylactic Treatment

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2021 Meta ULC. All rights reserved